CLINICAL_TRIALS
trial_result
· 2022-01-13
Clinical Trial Update: Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial evaluated pre-operative olanzapine as a prophylactic antiemetic in oncologic patients undergoing surgery, with completion repor…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Postoperative Nausea, Postoperative Nausea and Vomiting | Phase 2, Phase 3 | Status: COMPLETED